8-K: Philip Morris International Reports Strong Q1 2025 Results, Raises Full-Year EPS Forecast

Philip Morris International (PMI) announced strong first-quarter 2025 results, driven by smoke-free product growth, and raised its full-year adjusted diluted EPS forecast.

Summary

• Philip Morris International (PMI) reported a 24.6% increase in reported diluted EPS to $1.72 for the first quarter of 2025.
• Adjusted diluted EPS grew by 12.7% to $1.69, and by 17.3% excluding currency impacts.
• The company's smoke-free business accounted for 42% of total net revenues and 44% of total gross profit, with net revenues increasing by 15.0% (20.4% organically).
• Shipment volumes for smoke-free products increased by 14.4%.
• PMI has raised its full-year adjusted diluted EPS growth forecast to double-digit in dollar terms.
• The company declared a regular quarterly dividend of $1.35 per share, or an annualized $5.40 per share.

Sentiment

Score: 8

Explanation: The document presents a positive outlook with strong financial results, growth in key segments, and an increased EPS forecast. The management's confidence and strategic focus on smoke-free products contribute to a favorable sentiment.

Positives

• Strong growth in the smoke-free business, with significant increases in net revenues, gross profit, and shipment volumes.
• IQOS continues to strengthen its position as the second-largest nicotine brand in markets where it is present.
• Significant growth in ZYN nicotine pouch shipments in the U.S.
• Increased market share for IQOS HTUs in Japan and Europe.
• Raised full-year adjusted diluted EPS growth forecast.
• Declared regular quarterly dividend of $1.35 per share.

Negatives

• Negative geographic mix partially offset strong pricing in combustibles, resulting in flat net revenues.
• The estimated total market for cigarettes and HTUs decreased in Europe.
• A change in commercial model in Indonesia resulted in lower net revenue growth.

Risks

• Uncertain and volatile global economic environment.
• Excise tax increases and discriminatory tax structures.
• Increasing marketing and regulatory restrictions.
• Health concerns relating to the use of tobacco and other nicotine-containing products.
• Litigation related to tobacco and/or nicotine use and intellectual property.
• Intense competition.
• The effects of global and individual country economic, regulatory and political developments, natural disasters and conflicts.
• Unfavorable currency exchange rates and currency devaluations.
• Adverse changes in applicable corporate tax laws.
• Adverse changes in the cost, availability, and quality of tobacco and other agricultural products and raw materials.

Future Outlook

PMI forecasts full-year 2025 reported diluted EPS to be in the range of $7.01 to $7.14 and adjusted diluted EPS to grow by 12.0% to 14.0% (or 10.5% to 12.5% excluding currency).

Management Comments

• 'We achieved exceptionally strong performance in the first quarter, with continued volume growth supporting an excellent top-line performance and very strong margin expansion,' said Jacek Olczak, Chief Executive Officer.
• 'Our smoke-free business goes from strength to strength, delivering organic growth of over 20% in net revenues and over 33% in gross profit.'
• 'We remain confident in our ability to deliver superior results, despite an uncertain and volatile global economic environment, and now forecast double-digit adjusted diluted EPS growth in dollar terms for the full-year.'

Industry Context

The announcement highlights PMI's continued shift towards smoke-free products, aligning with the broader industry trend of reducing reliance on traditional cigarettes. The growth in smoke-free products, particularly IQOS and ZYN, positions PMI well in a changing market landscape.

Comparison to Industry Standards

• PMI's focus on smoke-free products mirrors the strategies of competitors like British American Tobacco (BAT) and Altria, who are also investing heavily in alternative nicotine products.
• The growth in the heat-not-burn category, where PMI holds a significant volume share (approximately 77%), indicates a strong competitive position compared to other players in this segment.
• The success of ZYN in the U.S. positions PMI to compete with Swedish Match (now part of PMI) and other nicotine pouch manufacturers.
• PMI's adjusted diluted EPS growth forecast of 12.0%-14.0% is a key metric for investors to compare against industry peers and assess the company's financial performance.

Stakeholder Impact

• Shareholders will benefit from the increased EPS and dividend payments.
• Employees will benefit from the company's growth and success.
• Customers will have access to a wider range of smoke-free products.
• Suppliers will benefit from the company's increased demand for raw materials and components.

Next Steps

• PMI will continue to focus on growing its smoke-free business and expanding its product portfolio.
• The company will monitor the global economic environment and adjust its strategies as needed.
• PMI will continue to invest in research and development to support its smoke-free product innovation.
• The company will file its Quarterly Report on Form 10-Q for the first quarter ended March 31, 2025, in the coming days.

Key Dates

Keywords

Philip Morris International, PMI, Earnings, Smoke-free products, IQOS, ZYN, HTU, EPS, Financial results, Dividend